Consent for the use of cookies and other tools

Tools and cookies used on the website collect information about visitors in anonymized form. Your consents enable us to ensure the functioning of all website features, customize certain content specifically for you, and continuously improve the website by analyzing visits.

Types of Cookies

I consent to the website use of tools, including cookies, which ensure full functionality and an appropriate level of security. I understand that without this, the website cannot offer proper functioning, such as website navigation, customization of appearance, and access to specific parts of the website.

I consent to the website use of tools, including cookies, which collect anonymized data about website visitors. I understand that without this, website administrators cannot analyze site traffic and usage patterns to improve the user experience on the website.

Changes were successfully saved

News

Customize list

The possibility of filtering records
Reset

Results

Number of results: 42, page 3 of 3

  • Genetic code

    University of Ljubljana participates in ground-breaking research proving the advantages of prescribing medication based on genetic code

    The research findings of an international group from seven countries, headed by researchers from Leiden University Medical Centre (LUMC), and involving the participation of researchers from the Faculty of Medicine of the University of Ljubljana, show that patients experience as much as 30% fewer serious adverse side effects of medication if the choice of medicines is adapted to their genetic code. The study, which was published in medical journal The Lancet, is the first to demonstrate the advantages of prescribing medication from various therapeutic groups based on the genetic code of the individual patient.

  • SIMBA team

    SIMBA innovation in the fight against superbacteria

    Innovation offers faster and cheaper solution in finding new active substances in the fight against superbacteria

    The growing phenomenon of superbacteria, as we call bacteria that are resistant to multiple antibiotics, is a global health problem. The problem is exacerbated by the merging of bacteria in biofilms, which offers them protection and survival in very harsh conditions and facilitates the transmission of resistance. For this very reason the global development of new antibiotics is focused on their effects on other properties of the bacteria, such as attaching bacteria to the surface, movement or interaction between bacteria, and not just on survival. The new orientation of development urgently requires a new methodology.